Home > Gastroenterology > Transanal minimally invasive surgery an option for certain rectal cancer patients

Transanal minimally invasive surgery an option for certain rectal cancer patients


Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22
Journal
JAMA Surgery
Reuters Health - 27/11/2020 - In carefully selected rectal cancer patients, transanal minimally invasive surgery (TAMIS) is an option when local excision (LE) will likely be curative, researchers say. Dr. Sam Atallah and Dr. Sergio Larach, colon and rectal surgeons in private practice in Orlando, reviewed the literature and wrote an overview of TAMIS, a method to locally excise premalignant and select malignant rectal lesions with curative intent. Among the key points, as reported in JAMA Surgery: - TAMIS was developed in 2009 as an alternative to traditional LE techniques, such as the Parks transanal excision (TAE); transanal endoscopic microsurgery (TEM) preceded TAMIS and was developed in 1984. - TAMIS outcomes seem to be comparable to those achieved with TEM; results from a multi-institutional analysis of 428 patients who underwent either TEM or TAMIS for LE showed a cumulative five-year disease-free survival of 80%(TAMIS) versus 78% (TEM), with no differ...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on